FindTrial
Sign In

The effect of dexemathasone solution pretreatment peripherally inserted central catheters(PICC) in prevention of phlebitis among cancer patients: a single-canter, randomized double-blind controlled trial

The effect of dexemathasone solution pretreatment peripherally inserted central catheters(PICC) in prevention of phlebitis among cancer patients: a single-canter, randomized double-blind controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15006022
Enrollment
Unknown
Registered
2015-02-26
Start date
2015-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Phlebitis

Interventions

Dexemathasone group one:Dexemathasone 0.04mg/ml
Dexemathasone group two :Dexemathasone 0.08mg/ml
Control group:0.9%Nacl

Sponsors

Mianyang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 to 75 years old; 2. pathologically diagnosed as malignant; 3. blood tests in the normal range; 4. patients willing to participate in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patient platelets less than 100*10^9/L before catheter, prothrombin time exceeds the upper limit of normal 3s; 2. patients exist phlebitis before catheter, and have skin damage, ulceration.

Design outcomes

Primary

MeasureTime frame
Incidence of phlebitis;—

Secondary

MeasureTime frame
Blockage rate;Catheter-related bloodstream infections;Pain scores;—

Countries

China

Contacts

Public ContactHua-ping, Huang
jrzhou26@aliyun.com+86 0816-2239671

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026